Divis Laboratories Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Divis Laboratories Quarterly Results    (DIVI)

Here are the latest quarterly results of Divis Laboratories. For more details, see the Divis Laboratories financial fact sheet and Divis Laboratories share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Divis Laboratories Quarterly Results

No. of Mths
Qtr. Ending
3
Dec-17
3
Mar-18
3
Jun-18
3
Sep-18
3
Dec-18
3
Mar-19
3
Jun-19
3
Sep-19
8-Qtr Chart
Click to enlarge
Net Sales Rs m10,37910,8809,95312,85013,42912,56411,39914,456 
Other income Rs m170482488801346417316470 
Turnover Rs m10,54911,36110,44113,65113,77512,98211,71614,926 
Expenses Rs m7,1177,0156,4357,7098,1968,4537,6139,550 
Gross profit Rs m3,2613,8653,5195,1415,2334,1113,7864,906 
Depreciation Rs m374388416424425423438459 
Interest Rs m3-262251338 
Profit before tax Rs m3,0553,9613,5845,5165,1294,1043,6614,879 
Tax Rs m8081,3459231,5391,3341,2109881,311 
Profit after tax Rs m2,2472,6162,6623,9773,7952,8942,6743,568 
Gross profit margin %31.435.535.440.039.032.733.233.9 
Effective tax rate %26.533.925.727.926.029.527.026.9 
Net profit margin %21.624.026.730.928.323.023.524.7 
Diluted EPS Rs 8.5 9.9 10.0 15.0 14.3 10.9 10.1 13.4  
Diluted EPS (TTM) Rs 32.7 32.8 36.1 43.3 49.2 50.2 50.2 48.7  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Divis Laboratories 2QFY20 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   TTK HEALTHCARE  SHASUN PHARMA  LUPIN  SUN PHARMA  NOVARTIS  

Compare DIVIS LABORATORIES With:   TTK HEALTHCARE  SHASUN PHARMA  LUPIN  SUN PHARMA  NOVARTIS  

Compare DIVIS LABORATORIES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Jumps 350 Points; Tata Motors and Vedanta Top Gainers(12:30 pm)

Share markets in India are presently trading on a strong note. Benchmark indices opened higher today tracking global markets on renewed optimism about a US-China trade deal.

Views on news

DIVIS LABORATORIES Announces Quarterly Results (2QFY20); Net Profit Down 10.3% (Quarterly Result Update)

Nov 11, 2019 | Updated on Nov 11, 2019

For the quarter ended September 2019, DIVIS LABORATORIES has posted a net profit of Rs 4 bn (down 10.3% YoY). Sales on the other hand came in at Rs 14 bn (up 12.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES 2018-19 Annual Report Analysis (Annual Result Update)

Oct 10, 2019 | Updated on Oct 10, 2019

Here's an analysis of the annual report of DIVIS LABORATORIES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

DIVIS LABORATORIES Announces Quarterly Results (1QFY20); Net Profit Up 0.4% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, DIVIS LABORATORIES has posted a net profit of Rs 3 bn (up 0.4% YoY). Sales on the other hand came in at Rs 11 bn (up 14.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

Use My Secret to Increase Your Trading Profits Today

Dec 10, 2019

What to do after every trade.

A Simple, 7-Step Checklist for Your Trading Success

Dec 4, 2019

What we can learn from one of the greatest traders to have ever lived.

Blue Chips Are Passe. Get into these Stocks for Outstanding Gains in 2020 (Profit Hunter)

Dec 5, 2019

This corner of the market could provide more returns than blue chips in 2020.

Make the Most of the Smallcap Rebound with These Stocks (Profit Hunter)

Dec 3, 2019

Even amid a gloomy economic scenario, there are smallcaps that have grown earnings over last one and a half year and I believe these could be the strongest candidates for a smallcap rebound.

What Is the IPO Euphoria Signaling Us About the Markets? (The 5 Minute Wrapup)

Dec 2, 2019

2019 will be remembered as the year of great money-making IPOs...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

DIVIS LABORATORIES SHARE PRICE


Dec 13, 2019 02:09 PM

TRACK DIVIS LABORATORIES

  • Track your investment in DIVIS LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DIVIS LABORATORIES

DIVIS LABORATORIES - MYLAN COMPARISON

COMPARE DIVIS LABORATORIES WITH

MARKET STATS